Enzo Biochem, Inc. (ENZ) Reports Q2 Loss of $0.04
Enzo Biochem, Inc. (NYSE: ENZ) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $25 million, versus $23.7 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.